Overview

Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging

Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this study to evaluate the safety, tolerability and efficacy of BGE-117 in the treatment of anemia of aging in participants ≥ 65 years of age.
Phase:
Phase 2
Details
Lead Sponsor:
BioAge Labs, Inc.